rs10027479

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_152618.3(BBS12):​c.1381A>C​(p.Asn461His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00423 in 1,614,222 control chromosomes in the GnomAD database, including 255 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N461S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.023 ( 136 hom., cov: 33)
Exomes 𝑓: 0.0022 ( 119 hom. )

Consequence

BBS12
NM_152618.3 missense

Scores

7
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11O:1

Conservation

PhyloP100: 2.57

Publications

11 publications found
Variant links:
Genes affected
BBS12 (HGNC:26648): (Bardet-Biedl syndrome 12) The protein encoded by this gene is part of a complex that is involved in membrane trafficking. The encoded protein is a molecular chaperone that aids in protein folding upon ATP hydrolysis. This protein also plays a role in adipocyte differentiation. Defects in this gene are a cause of Bardet-Biedl syndrome type 12. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, May 2010]
BBS12 Gene-Disease associations (from GenCC):
  • Bardet-Biedl syndrome 12
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P, Ambry Genetics, Myriad Women’s Health
  • ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0023567379).
BP6
Variant 4-122743273-A-C is Benign according to our data. Variant chr4-122743273-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 100564.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0784 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BBS12NM_152618.3 linkc.1381A>C p.Asn461His missense_variant Exon 2 of 2 ENST00000314218.8 NP_689831.2 Q6ZW61
BBS12NM_001178007.2 linkc.1381A>C p.Asn461His missense_variant Exon 3 of 3 NP_001171478.1 Q6ZW61
BBS12XM_011531680.3 linkc.1381A>C p.Asn461His missense_variant Exon 2 of 2 XP_011529982.1 Q6ZW61

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BBS12ENST00000314218.8 linkc.1381A>C p.Asn461His missense_variant Exon 2 of 2 1 NM_152618.3 ENSP00000319062.3 Q6ZW61
BBS12ENST00000542236.5 linkc.1381A>C p.Asn461His missense_variant Exon 3 of 3 2 ENSP00000438273.1 Q6ZW61

Frequencies

GnomAD3 genomes
AF:
0.0232
AC:
3528
AN:
152218
Hom.:
135
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0807
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00778
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000279
Gnomad OTH
AF:
0.0201
GnomAD2 exomes
AF:
0.00591
AC:
1487
AN:
251466
AF XY:
0.00435
show subpopulations
Gnomad AFR exome
AF:
0.0826
Gnomad AMR exome
AF:
0.00318
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000132
Gnomad OTH exome
AF:
0.00261
GnomAD4 exome
AF:
0.00225
AC:
3288
AN:
1461886
Hom.:
119
Cov.:
64
AF XY:
0.00198
AC XY:
1438
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.0809
AC:
2709
AN:
33480
American (AMR)
AF:
0.00376
AC:
168
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000174
AC:
15
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5768
European-Non Finnish (NFE)
AF:
0.000106
AC:
118
AN:
1112006
Other (OTH)
AF:
0.00447
AC:
270
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
214
428
642
856
1070
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0232
AC:
3537
AN:
152336
Hom.:
136
Cov.:
33
AF XY:
0.0228
AC XY:
1697
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.0807
AC:
3352
AN:
41562
American (AMR)
AF:
0.00777
AC:
119
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.000279
AC:
19
AN:
68028
Other (OTH)
AF:
0.0199
AC:
42
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
176
353
529
706
882
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00820
Hom.:
90
Bravo
AF:
0.0263
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.0837
AC:
369
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.00773
AC:
938
Asia WGS
AF:
0.00346
AC:
12
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3Other:1
-
NEI Ophthalmic Genomics Laboratory, National Institutes of Health
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

May 30, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 05, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 20498079, 22025579, 27884173, 27894351) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:3
Jul 05, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 10, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bardet-Biedl syndrome 1 Benign:2
Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 15, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bardet-Biedl syndrome 12 Benign:2
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Bardet-Biedl syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.66
D;D
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.27
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.69
T;.
MetaRNN
Benign
0.0024
T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Uncertain
2.6
M;M
PhyloP100
2.6
PrimateAI
Benign
0.45
T
PROVEAN
Uncertain
-2.4
N;N
REVEL
Benign
0.15
Sift
Uncertain
0.0060
D;D
Sift4G
Uncertain
0.017
D;D
Polyphen
0.25
B;B
Vest4
0.30
MVP
0.70
MPC
0.44
ClinPred
0.045
T
GERP RS
0.49
Varity_R
0.14
gMVP
0.38
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10027479; hg19: chr4-123664428; COSMIC: COSV58562513; COSMIC: COSV58562513; API